Verastem (VSTM) Insider Files Form 4 for Minor 284-Share Sale
Rhea-AI Filing Summary
SEC Form 4 overview – Verastem, Inc. (VSTM)
On 06/16/2025 director Robert E. Gagnon reported the disposition of 284 common shares at $5.65 per share, an aggregate value of roughly $1.6 thousand. The sale was executed solely to satisfy statutory tax-withholding requirements related to the vesting of restricted stock units, according to the filing’s footnote. After the transaction Gagnon directly owns 42,242 shares; no derivative securities were traded or reported. Because the sale represents less than 1% of his holdings and is administrative in nature, the filing signals minimal change in insider alignment and no operational impact on Verastem.
Positive
- Director retains 42,242 shares, maintaining meaningful ownership alignment with shareholders.
- Sale explicitly for tax-withholding per footnote, reducing concern over sentiment-driven selling.
- Timely Section 16 filing demonstrates governance compliance.
Negative
- Insider sale, however small, can be perceived negatively by some market participants.
- No accompanying Rule 10b5-1 plan disclosure, leaving future sale cadence uncertain.
Insights
TL;DR – Small, tax-related sale; neutral market impact.
The 284-share sale is immaterial (<$2k) relative to volume and Gagnon’s remaining 42k-share stake. Footnote clarity that proceeds cover withholding mitigates negative interpretation often associated with insider selling. No derivatives or Rule 10b5-1 plan disclosed, suggesting a one-off administrative event. For investors, the filing neither alters earnings outlook nor hints at strategic shifts, so price impact should be negligible.
TL;DR – Routine compliance transaction; governance risk unchanged.
The director remains in compliance with Section 16 reporting timelines, filing within four days. Retention of 42,242 shares indicates continued economic exposure and board alignment. The use of shares to meet tax obligations is common practice and does not raise governance red flags. Overall, this event is non-impactful to shareholders’ governance considerations.
FAQ
How many Verastem (VSTM) shares did Robert Gagnon sell?
At what price were the VSTM shares sold?
Why did the insider sell VSTM shares?
How many VSTM shares does the director still own after the sale?
Were any derivative securities involved in this Form 4 filing?